Literature DB >> 16628382

Non-invasive diagnosis of in stent stenosis by stress 99m technetium tetrofosmin myocardial perfusion imaging.

Abdou Elhendy1, Arend F L Schinkel, Ron T van Domberg, Jeroen J Bax, Roelf Valkema, Don Poldermans.   

Abstract

BACKGROUND: The aim of this study was to assess the accuracy of stress 99m technetium tetrofosmin myocardial perfusion imaging for the diagnosis of in stent stenosis (ISS).
METHODS: We studied 72 patients who underwent exercise or dobutamine stress 99m technetium tetrofosmin imaging, 0.9+/-0.5 years after percutaneous coronary interventions in which stents were deployed. Coronary angiography was performed within 3 months of the stress test. ISS was defined as > or =50% stenosis in a coronary segment with previous stenting. Significant coronary artery disease (CAD) was defined as > or =50% stenosis within or outside the stented coronary segment.
RESULTS: The stent was deployed in 1 coronary artery in 52 patients, and in 2 coronary arteries in 20 patients (a total of 92 detected in 42 (58%) patients (51 stents). Reversible perfusion abnormalities were present in 34 of patients with ISS (sensitivity=81%, CI 70-94). Regional sensitivity for diagnosis of stenosis per stent was 76% (CI 65-88), specificity was 83% (CI 71-94) and accuracy was 79% (CI 69-85). Reversible perfusion abnormalities were detected in > or =2 vascular distributions in 15 of 22 patients with multi-vessel CAD and in 5 of 50 patients without (sensitivity for identifying multivessel CAD=68%, CI 50-89; specificity=90%, CI 82-98; and accuracy=83%, CI 75-90).
CONCLUSION: Stress 99m technetium tetrofosmin myocardial perfusion imaging is a useful non-invasive technique for the diagnosis of in stent stenosis and extent of CAD in patients with previous percutaneous coronary artery interventions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16628382     DOI: 10.1007/s10554-006-9087-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  18 in total

Review 1.  Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease.

Authors:  G A Beller; B L Zaret
Journal:  Circulation       Date:  2000-03-28       Impact factor: 29.690

2.  ACC/AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty).

Authors:  S C Smith; J T Dove; A K Jacobs; J W Kennedy; D Kereiakes; M J Kern; R E Kuntz; J J Popma; H V Schaff; D O Williams; R J Gibbons; J P Alpert; K A Eagle; D P Faxon; V Fuster; T J Gardner; G Gregoratos; R O Russell; S C Smith
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

Review 3.  Dobutamine stress myocardial perfusion imaging in coronary artery disease.

Authors:  Abdou Elhendy; Jeroen J Bax; Don Poldermans
Journal:  J Nucl Med       Date:  2002-12       Impact factor: 10.057

4.  Dipyridamole scintigraphy and intravascular ultrasound after successful coronary intervention.

Authors:  R Bachmann; U Sechtem; E Voth; J Schröder; H W Höpp; H Schicha
Journal:  J Nucl Med       Date:  1997-04       Impact factor: 10.057

5.  Technetium-99m-sestamibi SPECT to detect restenosis after successful percutaneous coronary angioplasty.

Authors:  E Milan; O Zoccarato; A Terzi; F Ettori; O Leonzi; L Niccoli; R Giubbini
Journal:  J Nucl Med       Date:  1996-08       Impact factor: 10.057

6.  Comparison of myocardial blood flow during dobutamine-atropine infusion with that after dipyridamole administration in normal men.

Authors:  E Tadamura; H Iida; K Matsumoto; M Mamede; S Kubo; H Toyoda; T Shiozaki; T Mukai; Y Magata; J Konishi
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

7.  Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise.

Authors:  J Lee; S C Chae; K Lee; J Heo; A S Iskandrian
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

8.  A reverse perfusion pattern during Technetium-99m stress myocardial perfusion imaging does not predict flow limiting coronary artery disease.

Authors:  E J Smith; A Hussain; M Manoharan; H J Testa; N P Curzen
Journal:  Int J Cardiovasc Imaging       Date:  2004-08       Impact factor: 2.357

9.  Long-term outcome of patients with silent versus symptomatic ischemia six months after percutaneous coronary intervention and stenting.

Authors:  Michael J Zellweger; Markus Weinbacher; Andreas W Zutter; Raban V Jeger; Jan Mueller-Brand; Christoph Kaiser; Peter T Buser; Matthias E Pfisterer
Journal:  J Am Coll Cardiol       Date:  2003-07-02       Impact factor: 24.094

10.  Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography.

Authors:  Abdou Elhendy; Arend F l Schinkel; Ron T van Domburg; Jeroen J Bax; Roelf Valkema; Don Poldermans
Journal:  J Nucl Cardiol       Date:  2003 Nov-Dec       Impact factor: 5.952

View more
  2 in total

Review 1.  Multidetector computed tomography angiography for assessment of in-stent restenosis: meta-analysis of diagnostic performance.

Authors:  Piet K Vanhoenacker; Isabel Decramer; Olivier Bladt; Giovanna Sarno; Erik Van Hul; William Wijns; Ben A Dwamena
Journal:  BMC Med Imaging       Date:  2008-07-31       Impact factor: 1.930

2.  Adenosine triphosphate stress 99mTc-methoxyisobutylisonitrile gated myocardial perfusion imaging efficacy in diagnosing stent restenosis following coronary stent implantation.

Authors:  Pengfei Zhang; Song Chen; Yang Li; Qiuhong Du; Lijuan Wang; Yingxian Sun; Yaming Li
Journal:  Exp Ther Med       Date:  2016-11-04       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.